Farmacovigilancia Rosa Mary Carmen

Pharmacovigilance Technical Meeting in Bolivia

On November 27, 2020; Rosa Campos Yaipén and Mary Carmen Chuquimia Socpaza, members of our Pharmacovigilance and Regulatory Affairs teams, participated on behalf of SCR Consultores based in Peru and Bolivia, respectively, in the first technical meeting on Pharmacovigilance, which was convened by the State Agency for Medicines and Technologies in […]

dispositivos medicos producto farmaceutico 1

MINSA approved modifications to the BMP and CPP or CLV Certificate for Sanitary Registry procedures, Importation of Pharmaceutical Products and Medical Devices and provisions for the operation of Pharmaceutical Establishments.

Noticias MINSA aprobó modificaciones al Certificado BMP y CPP o CLV para trámites de Registro Sanitario, Importación de Productos Farmacéuticos y Dispositivos Médicos y disposiciones para el funcionamiento de Establecimientos Farmacéuticos. El Ministerio de Salud a través del D.S. Nº 036-2020-SA, publicado el 31 de diciembre del 2020 en el Diario Oficial “El Peruano”, aprobó […]

The Challenge of Medical Devices in the COVID-19 Pandemic

On December 03, 2020; Walther Vicente Mallma, Alberto Conislla Vigo, Manuel Uriarte Dávila and Pierre Calderón Fernández, members of our Regulatory Affairs team, participated on behalf of SCR Consultores Peru headquarters in the Webinar "The Challenge of Medical Devices in the COVID-19 Pandemic", which was organized and summoned […]

milagros

Regulatory Aspects for the Reconditioning of Pharmaceutical Products and Medical Devices in Peru

Library Regulatory Aspects for the Reconditioning of Pharmaceutical Products and Medical Devices in Peru Milagros Arista Arévalo, Quality and Regulatory Affairs Specialist at our headquarters SCR Consultores Peru, has carried out the Regulatory Analysis "Regulatory Aspects for the Reconditioning of Pharmaceutical Products and Medical Devices in Peru" , which we invite you to review in the following […]

vial e inyectable 2

Modificaciones de Seguridad de la DIGEMID: Para las Especialidades Farmacéuticas que contienen “FLUOROURACILO”

Noticias Modificaciones de seguridad de la DIGEMID: Para las especialidades farmacéuticas que contienen “FLUOROURACILO” La DIGEMID a través de la R.D. Nº 9030-2020-DIGEMID/DPF/MINSA publicada el 21 de diciembre de 2020, dispuso lo siguiente: Los titulares de los registros sanitarios de las especialidades farmacéuticas vigentes que contengan FLUOROURACILO, deben incluir en la ficha técnica e inserto […]